|
|
 |
|
Viewing report
|
|
|
|
Iran Pharmaceutical Local Manufacturing Market Review, 2004-2008
Iran Pharmaceutical Consulting Services, March 2010, Pages: 231
Locally manufactured pharmaceuticals are dominant in the pharmaceutical consumption market of Iran. The value of this market reached US$1.5 billion in 2008 with a compound annual growth rate of 20% from 2005 to 2008. Although it lost 6% of its market value share within this period and reached to 65% in 2008, yet in terms of volume it is still the market shaper. Generic production with low prices is the main practice of local manufacturers. They benefit from favored government's regulations, which are simultaneously persuading international and multinational companies to manufacture their products locally and benefit from its advantages.
Analyzed in a five-year period (2004-2008), this report provides the latest detailed information available on the market of locally manufactured pharmaceuticals and allows you to investigate trends in its different segments. Furthermore, it enables you to identify opportunities and growth sectors, spot your competition among local manufacturers and evaluate local manufacturing possibilities if interest your business.
The report's factual approach makes it an essential reference for decision makers in pharmaceutical companies that interested to enter and expand their business in Iran's fast growing market and benefit from its lucrative opportunities.
This report presented in 17 chapters and categorized information in two standpoints:
1 Total local manufacturing market review
In this section detailed historic information is provided, some of which are local production market size by anatomical main groups classified based on Anatomical Therapeutic Chemical (ATC) Classification System, top 10 classes in terms of value by second, third and forth level of ATC, market main dosage forms and top 10 local manufacturers of each group of dosage forms in terms of volume, top 20 pharmaceutical molecules, top 20 products and top 10 local pharmaceutical companies.
2 Local manufacturing market analysis by anatomical main groups of ATC
The report segments import market into 14 anatomical main groups of ATC, including:
1. Alimentary tract and metabolism
2. Blood and blood forming organs
3. Cardiovascular system
4. Dermatologicals
5. Genitourinary system and sex hormones
6. Systemic hormonal preparations (excluding sex hormones and insulins)
7. Anti-infectives for systemic use
8. Antineoplastic and immunomodulating agents
9. Musculoskeletal system
10. Nervous system
11. Antiparasitic products, insecticides and repellents
12. Respiratory system
13. Sensory organs
14. Various
For each of above groups, detailed historic information is provided some of which are main therapeutic groups, main dosage forms, top 10 pharmaceutical molecules, top 10 products, and top 10 local manufacturers.
Please note:
- This report only includes finished product market and does not cover raw materials and intermediary market.
- This report excludes dietary supplement market.
Product samples
A sample for this product is available. Please Login/Register to download this sample.
Customers who bought this item also bought
Iran Pharmaceutical Import Market Review, 2004-2008
Iran Pharmaceutical Market Review, 2004-2008
Iran Healthcare and Pharmaceuticals Overview
Pharmaceutical and Healthcare Market in Poland 2011. Development Forecasts for 2011-2013
Pharmaceutical and Healthcare Market in Poland 2011. Development Forecasts for 2011-2013
Endocrinology Market to 2018 - Advanced Injection Devices for Growth Hormone and Somatostatin will Improve Ease of Use for Patients
Commercial Insight: Osteoporosis - Market players maximize revenue growth before the next challenging phase
Emerging Medical Technologies Spotlight, A Report Of Investment & Partnering Opportunities, 2011
Blood Banking & Blood Products - Global Strategic Business Report
Blood Banking and Blood Products - Global Strategic Business Report
|
|
|
|
